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Abstract
The peroxisomal proliferator-activated receptor c (PPARc) is a nuclear receptor that controls inflammation and immunity.
Innate immune defense against bacterial infection appears to be compromised by PPARc. The relevance of PPARc in
myeloid cells, that organize anti-bacterial immunity, for the outcome of immune responses against intracellular bacteria
such as Listeria monocytogenes in vivo is unknown. We found that Listeria monocytogenes infection of macrophages rapidly
led to increased expression of PPARc. This prompted us to investigate whether PPARc in myeloid cells influences innate
immunity against Listeria monocytogenes infection by using transgenic mice with myeloid-cell specific ablation of PPARc
(LysMCre6PPARc
flox/flox). Loss of PPARc in myeloid cells results in enhanced innate immune defense against Listeria
monocytogenes infection both, in vitro and in vivo. This increased resistance against infection was characterized by
augmented levels of bactericidal factors and inflammatory cytokines: ROS, NO, IFNc TNF IL-6 and IL-12. Moreover, myeloid
cell-specific loss of PPARc enhanced chemokine and adhesion molecule expression leading to improved recruitment of
inflammatory Ly6C
hi monocytes to sites of infection. Importantly, increased resistance against Listeria infection in the
absence of PPARc was not accompanied by enhanced immunopathology. Our results elucidate a yet unknown regulatory
network in myeloid cells that is governed by PPARc and restrains both listeriocidal activity and recruitment of inflammatory
monocytes during Listeria infection, which may contribute to bacterial immune escape. Pharmacological interference with
PPARc activity in myeloid cells might represent a novel strategy to overcome intracellular bacterial infection.
Citation: Abdullah Z, Geiger S, Nino-Castro A, Bo ¨ttcher JP, Muraliv E, et al. (2012) Lack of PPARc in Myeloid Cells Confers Resistance to Listeria monocytogenes
Infection. PLoS ONE 7(5): e37349. doi:10.1371/journal.pone.0037349
Editor: Laurel L. Lenz, National Jewish Health and University of Colorado School of Medicine, United States of America
Received January 23, 2012; Accepted April 18, 2012; Published May 21, 2012
Copyright:  2012 Abdullah et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereiche 670 and 704) and an institutional grant by BONFOR.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pknolle@uni-bonn.de
. These authors contributed equally to this work.
" These authors also contributed equally to this work.
Introduction
The peroxisome proliferator-activated receptor-gamma
(PPARc) is a member of the nuclear hormone-receptor superfam-
ily of ligand-activated transcription factors [1]. It is expressed in
different cell types of the immune system, e.g. macrophages/
monocytes [2] and lymphocytes [3]. Upon ligand binding, PPARc
heterodimerizes with the retinoid X receptor (RXR) and binds to
PPAR response elements located in the promoter region of
metabolic target genes [4]. Besides its well-studied role in
metabolism and cellular differentiation, PPARc is a negative
regulator of inflammatory gene expression and macrophage
activation [5,6]. PPARc exerts its anti-inflammatory effects in
part by trans-repression, i.e. negative interaction with pro-
inflammatory transcription factors like NFkB, or by stabilization
of co-repressor complexes such as SMRT or NCoR on promoters
of target genes [5]. Among the genes targeted by the inhibitory
function of PPARc are pro-inflammatory cytokines and chemo-
kines but also lineage-determining transcription factors, such as
RORct that promotes differentiation of pro-inflammatory TH17-
cells [7]. PPARc is known to have cross-regulatory function in
inhibiting innate immune stimulation elicited through ligand
binding to Toll like receptors [8]. Moreover, we and others have
demonstrated a negative influence of PPARc on the immune
stimulatory capacity of dendritic cells (DC) [9,10]. Inhibition of
PPARc in myeloid cells led to induction of systemic inflammation
even in the absence of challenge with an infectious agent [11].
There is a large number of endogenous ligands for PPARc that
primarily are derived from arachidonic acid metabolism and are in
part induced by immune mediators such as IL-4 and IL-13 [12].
Pharmacological stimulation of PPARc has been shown to lead to
an increased occurrence of bacterial infections in patients [13],
suggesting that PPARc plays a key role in anti-bacterial defense.
Also, certain gram-positive bacteria such as Mycobacterium
tuberculosis have been shown to increase the expression of
PPARc [14,15]. However, there is no study on the relevance of
PPARc in myeloid cells for the outcome of bacterial infection,
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anti-bacterial defense.
Listeria monocytogenes is a facultative intracellular Gram-positive
bacterial pathogen. Infection of humans and animals can lead to
serious, often fatal disease. In humans, disease is most common
among pregnant women, newborns, and immune compromised
individuals [16]. Murine listeriosis is used widely as a model to study
the immune response against intracellular bacterial infection [17].
Early after infection with L. monocytogenes, neutrophils and inflam-
matory monocytes phagocytose and kill invading bacteria. These
phagocytic cells secret TNF and IL-12 [18,19,20], that activate NK
cells to produce IFNc, which in turn activates bactericidal effector
functions of other phagocytes, such as oxidative burst and
production of nitric oxide (NO) [21,22]. Accordingly, mice lacking
these essential inflammatory mediators and mice lacking p47phox
oxidase or iNOS, which are deficient in ROS or NO production, all
display enhanced susceptibility to L. monocytogenes infection [23,24].
Recruitment of inflammatory monocytes to the site of infection, that
is driven by the chemokines MCP1 (CCL2) and MCP3 (CCL7), is
an important mechanism supporting development of innate
immunity against L. monocytogenes infection [25]. Mice lacking
CCL2 or CCR2 exhibit diminished inflammatory monocyte
recruitment to infection sites resulting in enhanced bacterial growth
and overwhelming infection [26].
It has remained unclear whether PPARc with its potent
regulatory activity on innate immune functions in myeloid cells
plays a regulatory role during infection with L. monocytogenes. Here
we address this question and provide clear evidence that PPARc
restricts innate immunity in myeloid cells against Listeria infection.
As infection with L. monocytogenes leads to increased expression of
PPARc our results reveal a so far unrecognized regulatory network
in myeloid cells that may be abused by L. monocytogenes to counter
innate immunity.
Materials and Methods
Mice
Wild-type C57BL6/J and PPARc
flox/flox mice [27] were
purchased from Charles River, LysM-Cre, IFNc
2/2, TNF
2/2
and CCR2
2/2 transgenic mice in C57BL6/J background were
previously described [28,29,30,31]. All animal studies were
approved by local authorities. Animals were bred and kept under
specific pathogen-free conditions and used at 8–12 weeks of age in
accordance with local animal experimentation guidelines. LysM-
specific PPARc knockout mice (LysM-PPARc
KO mice) were
generated by crossing PPARc
flox/flox mice with LysM-Cre
+/2
transgenic mice expressing Cre-recombinase under control of the
LysM promoter. These mice display no alterations in immune cell
frequencies.
Infection of mice and cells
If not indicated otherwise, mice were infected intraperitonealy
with 2610
4 CFU of wild type Listeria monocytogenes (EGDe strain).
Cells were infected in antibiotic free medium with Listeria
monocytogenes at a MOI of 10 for one hour followed by one step
wash with PBS and were further cultured in medium containing
50 mg/ml Gentamycin.
Uptake of fluorochrome labeled Listeria
Murine BMDM or PEC (10
6 cells) were infected with FITC-
labeled listeria (MOI 5 or 10) 1 ml medium. After 30 minutes of
incubation, cells were washed with PBS followed by passage
through a 30% sucrose layer to get rid of extracellular bacteria.
Uptake efficiency was assessed by flow cytometry following
staining with anti-Listeria antibody to discriminate between
intracellular and extracellular Listeria. To determine the infection
efficiency of the infected BMDM and PEC, cell lysates were plated
on BHI plated and incubated over night at 37uC and CFU/cell
was measured. FITC-labeled bacteria were obtained by incuba-
tion of wild type Listeria monocytogenes for 30 min at 37uC in PBS
containing 5 mM FITC (5,6)-fluorescein isothiocyanate mixed
isomer (Thermo Scientific)) at a density of 1610
9 CFU/ml
followed by three times wash with PBS.
Cells and cell culture
Peritoneal exudates cells (PEC) are collected from the peritoneal
cavity of mice by peritoneal lavage using PBS. To achieve
macrophage-rich exudates, mice were injected intraperitoneally
with 1 ml of 3% thioglycolate and PEC were collected 72 hrs
later. Cells were then let to adhere for 1 hr and non- adherent cells
were collected. Bone marrow derived macrophages from wild-type
or mutant mice were generated by collecting cells from mice tibiae
and femurs and culture them in RPMI 1640 medium supple-
mented with FCS, Glutamate, bME and 30% L929 cells
conditioned medium for 7 days. Cells were cultured and infected
as previously described [32]. Importantly, for all experiments
BMDM were cultured in antibiotic-free medium prior to infection
or adoptive transfer studies to eliminate remaining antibiotics that
may interfere with bacterial growth. The purity of BMDM
generated by the protocol used in this study was routinely .95%
as shown by a representative analysis of CD11b and F4/80
expression (Fig. S1).
Transfer of BMDM from LysM-PPARc
WT and LysM-
PPARc
KO
BMDM were generated as above from LysM-PPARc
WT and
LysM-PPARc
KO. On days 6, medium was replaced with fresh
medium lacking antibiotics. On day 7 of differentiation, 5610
6
cells were injected into the peritoneal cavity of IFNc2/2,
TNF2/2 or CCR22/2 mice. Two hours later mice were
infected with 2610
4 CFU/ml of Listeria monocytogenes.
Immunohistochemistry and immunofluorescence
microscopy
Murine BMDM (5610
5) were seeded on glass coverslips in 24-
well plates overnight in antibiotic free medium. Cells were then
infected with L. monocytogenes at MOI of 10 for 30 min. Cells were
then washed with pre-warmed medium and culture further in
medium containing 50 mg/ml Gentamycin (Sigma). At indicated
time points after infection, cells were washed three times with PBS
and were fixed with 4% paraformaldehyde, permeablized with
0.1% Saponin. Cells were incubated with anti-PPARc in PBS
containing 10% FCS and 0.1% Saponin for 1 h. After three
washes with PBS, cells were incubated for 1 h at room
temperature with FITC–labeled secondary antibody. After that,
cells were washed three times with PBS and mounted for
fluorescence microscopy. Cells were viewed with a 60 times oil
objective lens. Microscopy analysis was performed with an
Olympus FluoView IX71Microscope (Olympus).
Cell culture and infection prior gene expression profiling
Human macrophages were generated from peripheral blood
mononuclear cells (PBMC) obtained by Pancoll (PAN-Biotech,
Aidenbach, Germany) density centrifugation from buffy coats of
healthy donors. CD14
+ monocytes were then isolated from the
PBMC using CD14-specific MACS beads (Miltenyi Biotec)
according to the manufacturers protocol (routinely .95% purity).
PPARc Deletion Protects from Lethal Listeriosis
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+ monocytes were cultured in 6-well plates in RPMI1640
medium containing 10% FCS and differentiated into immature
macrophages using GM-CSF (500 U/ml; Immunotools, Frie-
soythe, Germany) for 72 hours. Only cultures with .95% CD14
+
CD68
+ macrophages purity were used for further analysis. Cells
were infected with wild type Listeria monocytogenes (EGDe strain)
using a MOI of 10. 24 hours after infection cells were washed
twice and lysed in Trizol (Invitrogen Life Technologies, USA)
prior RNA isolation. Only cultures with a cell viability of .80%
were used for further analysis.
Microarray procedure
RNA sample amplification, labeling and hybridization on
Illumina HT12 Sentrix BeadChips V4 were performed according
to the manufacturer’s instructions using an Illumina HiScan SQ.
(Table S1) summarizes the performed microarray experiments.
Bioinformatics Analysis
Data analyses were performed using Illumina Genome Studio
and Partek Genomics Suite (PGS). Datasets were generated in
Illumina and exported to PGS following the manufacturer’s
instruction. In PGS the quantile method was used for data
normalization. Differentially expressed genes were determined
using ANOVA. To identify PPARc target genes regulated during
infection of macrophages with Listeria a publically available dataset
(GSE21314) assessing genome-wide PPARc binding to DNA by
ChIP-Seq was downloaded from GEO. A table of genes most
closely located to PPARc binding sites in macrophages was
Figure 1. PPARc expression is induced in bone-marrow derived monocytes after infection with Listeria monocytogenes. (A) Time course of
PPARcexpressioninhumanmonocytesfollowingListeriamonocytogenesinfectiondetectedbyWesternblot.(B)PPARctargetgenes(n=80)withthemost
significant differential expression in human macrophages post infection. Gene expression differences (log scale) are visualized as a heat map following
hierarchical clustering of rows and columns (red=increased expression). (C,D) Time course of PPARc expression in bone marrow derived macrophages
(BMDM) post infection detected by Western blot or immunohistochemistry. (blue=DAPI staining the cell nucleus and Listeria DNA; green=PPARc).
doi:10.1371/journal.pone.0037349.g001
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data analysis tool HOMER (Hypergeometric Optimization of
Motif EnRichment). This list of genes was used to filter genes
differentially regulated in macrophages infected with Listeria in
contrast to non-infected macrophages (Table S3). For visualiza-
tion of the most differentially expressed PPARc target genes
(n=80) hierarchical clustering was performed using PGS and
plotted as a heatmap. The complete dataset is available at GEO
(GSE34103).
Immunoblot analysis
PPARc expression was detected by immunoblot using the
polyclonal anti-PPARc (Santa Cruz (H-100)) and anti b-tubulin
polyclonal antibody (Licor Bioscience) as previously described
[33].
Serum alanine aminotransferase (ALT) determination
Serum ALT was analyzed from whole blood using ALT strips
from Roche according to the manufacturers instructions. Mea-
surement was performed in a Reflovet machine from SCIL animal
care.
Flow cytometry
We used the following fluorochrome-labeled monoclonal
antibodies from e-Bioscience: Anti-CD11b-PerCp-cy5.5 (M1/
70), F4/80-FITC (BM8), Ly6C-APC (HK1.4), CD11b-Pacific
Blue (M1/70) and CD3-PE (G4.18) and the live/dead-APC-Cy7
(near-red) cell staining from Invitrogen. To determine the absolute
cell numbers fixed numbers of CaliBRITEH Beads (BD) were
added to each sample before analysis as internal reference.
Analysis, was performed on a FACSCanto (BD) and analyzed data
with Flow-JoH software (Tree Star). For flow cytometric analysis of
intrahepatic leukocytes, livers were perfused with 20 mL 400 mg/
ml collagenase type-IV (Sigma) in Hank’s balanced salt solution
(HBSS), minced with scissors and subsequently digested for
15 minutes with 400 mg/ml collagenase type-IV in HBSS at
37uC. Digested extracts were pressed through 70-mm cell strainers
to gain single-cell suspensions. Liver single cell suspension was
subjected to density gradient centrifugation (25% vs 50% PercollH
(GE Healthcare)) at 2000 rpm for 20 minutes at 25uC. Leukocytes
were collected from the interphase after centrifugation, washed
twice with HBSS containing 2% bovine serum albumin and
subjected to antibody staining for FACS analysis.
Determination of cytokines, NO (Nitrite) and ROS
IFNc, TNF, IL-6, IL-12 were determined in supernatants of cell
culture or sera of mice by ELISA using purified and biotinylated
antibodies to IFNc, TNF, IL-6 and IL-12 (e-Bioscience). Nitrite
concentrations were determined in the supernatant of cells 24 hrs
prior to infection using the Griess Reagent Kit (Invitrogen)
Figure 2. Enhanced resistance of LysM- PPARc
KO mice to lethal infection with Listeria monocytogenes. (A) Survival of LysM- PPARc
KO mice
and LysM- PPARc
WT littermates after intraperitoneal infection with 2610
4 (LD 50) 5610
5 (LD 80), 2610
6 (1006 LD50) CFU of Listeria. (n=10, one
representative out of three experiments is shown ). LD 50: p=0.04; LD 80; 0.01; 1006LD50: not significant difference. (B, C) Colony forming units of
Listeria monocytogenes in liver (B)andspleen(C)of LysM- PPARc
WT or LysM- PPARc
KO mice infectedi.p. with 2610
4 CFU. (n=9); significance ** p=0.005.
doi:10.1371/journal.pone.0037349.g002
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(ROS) production was determined using OxyBURSTH Green
H2DCFDA (Life Technologies) according to the manufacturer’s
protocol.
Quantitative real-time PCR analysis
RNA from macrophages was extracted using the RNeasy mini
kit (QIAGEN). Reverse transcription of RNA into cDNA was
performed using SuperScript III (Invitrogen). Quantitative Real
Time PCR (TaqMann) for PPARc, IFNc, TNF, IL-6, IL-12,
MCP-1, MCP3, CCR2 and GAPDH expression were performed
using pre-designed primers and probes (Gen Expression Assay)
from Applied Biosystems on an ABiPrism 7900 HT cycler
(Applied Biosystems) according to the manufacturer’s instructions.
All gene expression data are presented as relative expression to
GAPDH.
Ethics statement
The animal experiments within this manuscript were performed
according to the guidelines for animal care enforced by the EU
(EU Directive 86/609/EEC) and the state Northrhein Westphalia.
The study protocol was approved by the local authorities of the
state Northrhein Westphalia (8.87-50.10.31.09.033). Ethics ap-
proval for obtaining peripheral blood from healthy volunteers was
given by the local ethics committee at the University Hospital
Bonn and blood was only drawn from healthy donors after written
consent was obtained.
Statistical analysis
All statistical analysis was performed by Student’s t test.
Significant values are indicated as follows: *, p,0.05; **, p,0.01;
and ***, p,0.001.
Results
Enhanced expression of PPARc following Listeria
infection in macrophages
As PPARc is known to be up-regulated during infection of
macrophages with Mycobacteria spp. or epithelial cells with Salmonella
spp. [14,33], we wondered whether infection of macrophages with
Listeria monocytogenes would also increase PPARc expression. We
observed a rapid and pronounced increase in the expression of
PPARc within 30 minutes after infection, as shown by immuno-
blot and immunofluorescence analysis of infected human mono-
cytes (Fig. 1A). To address the question whether such increase in
PPARc levels were accompanied by transcriptional changes
indicative of PPARc activation, we analyzed the entire transcrip-
tome of Listeria-infected human monocytes at a later time point
(24 hrs p.i.) compared to non-infected monocytes. We mapped
target genes of PPARc in monocytes recently published as ChIP-
seqencing data [34] onto the transcriptome of macrophages
infected with L. monocytogenes for a longer time period. Of the 891
genes with significant increase in gene expression (FC.2, p,0.05)
after infection, 125 genes were PPARc target genes (Table S2).
Of the 883 significantly suppressed genes after L. monocytogenes
infection 100 genes were previously identified to be PPARc
targets. The most differentially expressed genes are shown as a
heatmap after hierarchical clustering (Fig. 1B). We confirmed
these findings for bone marrow derived murine macrophages
(BMDM). Already 30 minutes after infection with L. monocyto-
genes we observed an increase in PPARc expression that was
detected by Western Blot and immunohistochemistry (Fig. 1C,D
and suppl. Fig. 2D). Taken together, these results strongly
suggested that Listeria infection not only led to increased expression
of PPARc but also increased activity as transcriptional regulator.
Myeloid cell-specific PPARc-ablation augments survival
of mice after L. monocytogenes infection
Given the early increase of expression of the anti-inflammatory
factor PPARc as well as the differential expression of important
PPARc target genes in Listeria-infected macrophages, we next
characterized the functional role of PPARc in myeloid cells in host
defense against infection with L. monocytogenes. To this end, we
generated a transgenic mouse with a myeloid cell-specific knock-
out of PPARc by crossing LysM-Cre mice with mice carrying loxP
sites within the PPARc gene (LysMCre6PPARc
fl/fl=LysM-
PPARc
KO)( Fig. S2A–C). The LD50 for Listeria infection in
wildtype littermates (LysM- PPARc
WT) was identical to that for
wildtype C57Bl/6 mice (2610
4 CFU, data not shown). LysM-
PPARc
WT and LysM- PPARc
KO mice were challenged with this
dose of L. monocytogenes and survival was determined. LysM-
PPARc
KO mice showed an improved survival compared to
wildtype littermates (Fig. 2A), indicating that absence of PPARc
in myeloid cells enhances innate immune defense against Listeria
infection. Almost 80% of LysM- PPARc
KO mice even resisted
infection with 20-fold higher numbers of bacteria, a dose where all
wildtype littermates succumbed to infection (Fig. 2A). However,
when infected with very high numbers of bacteria (200 fold LD50),
LysM- PPARc
KO mice succumbed faster than their wildtype
littermates (Fig. 2A), revealing a limitation of the gain of
protective myeloid cell function upon ablation of PPARc.
Next, we determined whether the improved resistance to L.
monocytogenes infection in LysM- PPARc
KO mice was associated
with an improved clearance of infecting bacteria. Time kinetic
analysis showed already at d1 after infection (2610
4 CFU), that
LysM- PPARc
KO mice better controlled bacterial infection than
LysM- PPARc
WT (Fig. 2B and C). In LysM- PPARc
WT mice,
little if any decline in bacterial numbers was observed until d4 p.i.
In contrast, in LysM- PPARc
KO mice the numbers of L.
monocytogenes in liver and spleen decreased over the entire time
period investigated. At d3 p.i., the bacterial burden in the spleen of
LysM- PPARc
KO mice was 100 fold lower compared to LysM-
PPARc
WT mice (Fig. 2C). Interestingly, increased clearance of
bacteria was not accompanied by an exaggerated immune reponse
against infected tissue, because only a mild elevation of serum
ALT levels was observed in LysM- PPARc
KO mice infected with
L. monocytogenes (LD50 and LD80) (Fig. S3). Taken together, these
Figure 3. Similar phagocytic capacity in myeloid cells from LysM- PPARc
WT and LysM- PPARc
KO mice. Bone marrow derived
macrophages (BMDM) and peritoneal exudates cells (PEC) from LysM- PPARc
WT and LysM- PPARc
KO mice were infected with FITC-labelled Listeria at
MOI 2 or MOI 5). (A) Mean fluorescence intensity (MFI) of FITC positive cells was assessed by flow cytometry. and (B) Percentage of Listeria containing
macrophages (FITC positive). (C) BMDM or PEC from LysM- PPARc
WT and LysM- PPARc
KO mice were infected with Listeria (MOI 10) and intracellular
Listeria growth was determined as CFU/ml in the lysates of infected cells. The p values for titres of WT vs. KO at 4 hrs p.i. were ,0.05 and ,0.01 for
BMDM and PEC, respectively. (D–F) BMDM from LysM- PPARc
WT and LysM- PPARc
KO mice were infected with Listeria (MOI of 10). The capacity to
produce reactive oxygen species (ROS) in Listeria infected macrophages was determined by the OxyBURST reagent (D). At 24 hrs p.i. the
concentration of NO2- as surrogate marker for the production of reactive nitrogen intermediates was determined with Griess reagent (E). Expression
of iNOS was analyzed by quantitative RT-PCR (F).
doi:10.1371/journal.pone.0037349.g003
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immune responses and bacterial clearance during the early phase
of the immune response against intracellular infection with L.
monocytogenes.
Loss of PPARc in myeloid cells enhances bactericidal
activity and expression of pro-inflammatory mediators
after L. monocytogenes infection in vitro
As we observed improved bacterial clearance in LysM-
PPARc
KO mice we next investigated the influence of PPARc on
molecular mechanisms known to be critical for control of bacterial
infection, such as phagocytosis and generation of listeriocidal
mediators like reactive NO and ROS [16,21]. We did not detect
any differences in the extent of phagocytic uptake or the
percentage of phagocytic macrophages isolated from bone marrow
or peritoneal cavity of either LysM- PPARc
KO or LysM-
PPARc
WT mice (Fig. 3A and B). Similarly, no difference in
phagocytic uptake of fluorescently labeled L. monocytogenes was
observed (Fig. 3A and B), thus excluding that increased
phagocytosis by PPARc
KO macrophages was responsible for
improved bacterial clearance. Instead, PPARc
KO macrophages
more efficiently controlled the growth of intracellular L. monocy-
togenes than PPARc
WT macrophages (Fig. 3C). Along this line, we
observed that macrophages from LysM- PPARc
KO produced
significantly higher level of the listeriocidal mediators ROS and
NO2- after infection with L. monocytogenes compared to macro-
phages from LysM- PPARc
WT (Fig. 3D and E). As ROS
production was more pronounced in PPARc-deficient macro-
phages already early during bacterial infection (Fig. 3D) this may
explain the improved subsequent early control of intracellular
bacterial growth. These results were corroborated by the
observation that iNOS expression was also enhanced at early
time points in Listeria-infected PPARc-deficient macrophages
(Fig. 3F), findings that are in line with reports that PPARc
controls expression of pro-inflammatory and bactericidal media-
tors by interfering with NF-kB signaling [4,6,35].
Absence of PPARc in myeloid cells augments production
of pro-inflammatory mediators upon L. monocytogenes
infection
Myeloid cells secrete pro-inflammatory mediators, which are
essential for innate immune responses against Listeria infection
[36,37]. To further characterize the role of PPARc in myeloid cells
during L. monocytogenes infection, we determined expression of
relevant pro-inflammatory cytokines after L. monocytogenes infection
in vivo. We observed increased expression of IFNc, TNF, IL-12
and IL-6 in liver and spleen of infected mice (Fig. 4A and B) and
cytokine expression was found to be significantly higher in organs
of PPARc
KO mice at d1-d3 p.i. when compared to PPARc
WT
mice (Fig. 4A and B). In contrast, at d4 p.i. there was a
pronounced reduction of IFNc and TNF in PPARc
KO compared
to PPARc
WT mice (Fig. 4A and B), which can be explained by
the rapid clearance of L. monocytogenes from LysM- PPARc
KO mice
as demonstrated before. The early increased induction of
proinflammatory cytokines was also observed in peritoneal
macrophages isolated from PPARc
KO mice (Fig. S4), thus
confirming the control function of PPARc for these cytokines.
To provide further evidence for the role of PPARc in myeloid
cells, we analyzed the production of inflammatory cytokines in L.
monocytogenes infected macrophages derived from PPARc
KO or
PPARc
WT mice. Following L. monocytogenes infection in vitro,
macrophages from PPARc
KO mice produced more IFNc, TNF,
IL-6 and IL-12 compared to macrophages from PPARc
WT mice
(Fig. 5A). These results demonstrate an important cell-intrinsic
control function of PPARc for pro-inflammatory cytokine
production in myeloid cells after infection with L. monocytogenes.
To investigate whether PPARc-mediated control of macrophage-
derived inflammatory cytokines was relevant for bactericidal
activity of neighboring cells, macrophages from wildtype
C57BL/6 mice were infected with L. monocytogenes and cultured
in the presence of conditioned medium from Listeria-infected
peritoneal macrophages isolated from LysM- PPARc
KO or LysM-
PPARc
WT mice. While wildtype macrophages incubated in
conditioned medium from infected PPARc
KO macrophages were
able to restrict the growth of intracellular Listeria immediately after
infection, macrophages cultured in conditioned medium from wild
type macrophages did not rapidly control Listeria growth (Fig. 5B).
These results indicate that ablation of PPARc in myeloid cells also
functioned in a paracrine fashion to increase anti-bacterial
immunity in neighboring cells by proinflammatory cytokines.
Deletion of PPARc in myeloid cells augments recruitment
of inflammatory monocytes to sites of L. monocytogenes
infection in vivo
The recruitment of inflammatory monocytes that produce TNF
and NO for control of Listeria infection has been demonstrated to
be crucial for anti-bacterial innate immune defense [38]. Clearly,
the recruitment of Ly6C
highCD11b
+ inflammatory monocytes to
sites of infection was increased from d2 p.i. in LysM- PPARc
KO
mice compared to LysM- PPARc
WT mice (Fig. 6A and Fig. S5).
The increased number of inflammatory monocytes in LysM-
PPARc
KO mice was not caused by reduced apoptosis as measured
by expression of activated Caspase 3/7, bax, bcl2 by Western
blotting (Fig. S6). As recruitment of these cells requires
chemokines such as CCL2, CCL7 [23,25] and adhesion molecules
such as CD54 [39], we investigated the expression of these
molecules in LysM- PPARc
KO mice. We detected a similar up-
regulation of these genes in lysates from liver (Fig. 6B) and spleen
(Fig. 6C) of LysM- PPARc
KO mice. Consistent with this finding,
in myeloid cells isolated from the peritoneal cavity after L.
monocytogenes infection we found a significant increase in gene
expression for CCL2 and CCL7 as well as the corresponding
chemokine receptor CCR2, which was most pronounced at d1
and d2 after infection (Fig. S7). As entry of inflammatory
monocytes into infected liver requires CD54 expression on liver
endothelium [39], we exposed primary liver sinusoidal endothelial
cells in vitro to supernatants of Listeria-infected macrophages from
PPARc
KO or LysM- PPARc
WT mice. There was a significant
induction of CD54 expression on LSEC when exposed to
supernatants of Listeria-infected but not non-infected macrophages
from PPARc
KO mice (Fig. 6D), which suggests that macrophages
from PPARc
KO mice secrete mediators such as TNF and IFNc
that act on LSEC to upregulate CD54 expression. These results
indicate that PPARc in myeloid cells controls both, chemokine as
well as adhesion-molecule driven recruitment of inflammatory
monocytes to sites of infection.
Figure 4. Enhanced expression of inflammatory cytokines in LysM-PPARc
KO mice during infection with Listeria in vivo. (A and B) LysM-
PPARc
WT and LysM- PPARc
KO mice were infected i.p. with 2610
4 CFU of Listeria. At indicated time points, expression of IFNc, TNF, IL-1b, IL-6 and IL-12
was determined in the liver (A) and spleen (B) of mice (n=5) by qRT-PCR. The data shown are means 6 SE of three independent experiments.
doi:10.1371/journal.pone.0037349.g004
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37349Figure 5. Enhanced effector functions following abelation of PPARc from myeloid cells. (A) BMDM from LysM- PPARc
WT and LysM-
PPARc
KO mice were infected in vitro with L.monocytogenes at a MOI 10. Expression of IFNc, TNF, IL-1b, IL-6 and IL-12 was determined 6 hrs post
infection in cell culture supernatant by ELISA. The data shown are means 6 SE of three independent experiments. (B) Looking at the paracrine effects
of PPARc ablation in myeloid cells, we infected BMDM from wild type C57BL/6 mice with Listeria at an MOI of 10 and incubated them with sterile
filtered conditioned medium from PPARc
WT or PPARc
KO macrophages infected previously for 18 hrs with L. monocytogenes; at the indicated time
points intracellular Listeria growth was determined as CFU/ml in the lysates of infected cells. Experiments were performed in triplicates. One
representative out of four experiments is shown. The p value for titers of wt vs. ko at 4 hrs post infection were ,0.05.
doi:10.1371/journal.pone.0037349.g005
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control L. monocytogenes infection in vivo
Finally, we elucidated the relevance of PPARc-mediated
regulation in myeloid cells to clear L. monocytogenes infection in
vivo. As the soluble mediators IFNc and TNF are crucial to control
infection of mice deficient for either of these mediators that rapidly
succumb to infection [40,41], we chose to adoptively transfer
macrophages from LysM- PPARc
KO or LysM- PPARc
WT into the
peritoneal cavity of IFNc
2/2 or TNF
2/2 mice prior to infection
of the mice. All knockout mice succumbed on day 2 p.i. and those
mice that received wildtype macrophages succumbed on day 3 p.i.
(Fig. 7A). In contrast, 75–80% of IFNc
2/2 or TNF
2/2 mice that
received PPARc
KO macrophages survived until the end of the
observation period (Fig. 7A). Direct comparison of the bacterial
load in organs from these mice at d2 p.i. revealed that only
IFNc
2/2 or TNF
2/2 mice receiving PPARc
KO macrophages had
lower levels of bacteria in liver and spleen compared to mice
receiving PPARc
WT macrophages (Fig. 7B). These results clearly
demonstrate that ablation of PPARc renders myeloid cells more
competent to control infection in vivo presumably through the
increased expression of soluble mediators as transfer of these cells
restored resistance towards Listeria infection in cytokine-deficient
animals. To address the question whether the gain of function
upon PPARc ablation in macrophages is already sufficient to
improve control of Listeria infection in the absence of inflammatory
monocytes, we adoptively transferred PPARc-deficient macro-
phages into CCR2
2/2 mice [25]. Under these experimental
conditions, we also observed reduced numbers of bacteria in the
liver and spleen (Fig. 7C), which indicates that the improved
function of PPARc-deficient macrophages alone is already
sufficient to control infection. Collectively, we report here the
discovery of a so far unknown regulatory network in myeloid cells
that is governed by PPARc and which plays a key role in the
control of innate immune responses to L. monocytogenes infection.
Discussion
The immune response against infection with intracellular
bacteria is orchestrated by myeloid cells [16,36,37]. These cells
initiate and amplify innate immune responses leading to imme-
diate reduction of bacteria or infected cells, and also serve as
important link for the induction of adaptive immunity to achieve
long-lasting protective immunity. Here, we have investigated the
role of the potent anti-inflammatory transcription factor PPARc in
regulating the early innate immune response of myeloid cells
against infection with L. monocytogenes. Our results identify a so far
unknown central role of PPARc in the coordination of listeriocidal
functions and recruitment of inflammatory monocytes to the site of
infection.
The expression of PPARc has been shown to be augmented in
macrophages after infection with pathogenic bacteria such as
Mycobacterium tuberculosis and Salmonella enteridis [14,15,33]. Here, we
demonstrate that also the intracellular bacterium L. monocytogenes
increases PPARc expression rapidly within 30 minutes after
infection of primary murine macrophages. The molecular
mechanism underlying increased expression of PPARc remains
unclear and will require further investigation. It is important to
note, however, that this induction of a regulatory transcription
factor by Listeria infection occurs immediately upon infection and
before an inflammatory response was mounted. This is clearly
different from immunoregulatory mediators such as IL-10, which
typically are expressed after inflammation has been induced and
serves in many infections to restrict detrimental immunopathology
[42]. Although there is evidence that autoactivation may occur if
large numbers of PPARc are present in a cell [43], PPARc is a
ligand-activated receptor raising the question whether increased
expression levels were also associated with PPARc-activation.
Gene expression analysis of Listeria monocytogenes infected macro-
phages revealed regulation of PPARc responsive gene sets
indicating that PPARc has likely undergone ligand-activation
after infection. It is possible that other cell populations such as
mast cells through production of IL-4 may contribute to increased
production of endogenous PPARc ligands in vivo [44]. However,
our data demonstrating increased bactericidal function of
PPARc
KO compared to PPARc
WT macrophages against Listeria
infection in vitro suggest that there is also induction of endogenous
PPARc ligands in macrophages themselves. It appears likely that
L. monocytogenes infection induced increased expression of endog-
enous ligands as we have previously reported that following Listeria
infection of myeloid cells COX2 expression was induced [45], that
leads to generation of prostanoids that can serve as PPARc
ligands.
Given the potent anti-inflammatory effects of PPARc by
transrepression of NF-kB and stabilization of co-repressor com-
plexes on promoters of pro-inflammatory genes [1], such induction
of PPARc in macrophages upon bacterial infection may give rise
to escape from innate immune responses acting on various
immune effector mechanisms, because PPARc targets many pro-
inflammatory genes [8]. We investigated this question by
generating transgenic mice lacking PPARc in myeloid cells.
Indeed, myeloid-cell specific knockout of PPARc rendered mice
more resistant to infection with L. monocytogenes supporting the
assumption that PPARc expression can help bacteria to evade the
early phases of innate immunity. Lack of PPARc in myeloid cells
resulted in increased expression of essential inflammatory medi-
ators such as TNF, IFNc and IL-12, which in a paracrine fashion
stimulated further IFNc expression by NK cells (data not shown).
Our findings of increased expression in PPARc-deficient myeloid
cells are consistent with earlier reports that pro-inflammatory
mediators such as TNF and IFN are target genes of PPARc [34].
The lack of PPARc in myeloid cells also increased expression of
iNOS and production of the listeriocidal NO, which most likely
occurred indirectly through the augmented production of pro-
inflammatory mediators, because iNOS does not belong to
PPARc-regulated genes [34].
In addition to increased bactericidal activity, PPARc ablation in
myeloid cells resulted in enhanced recruitment of inflammatory
monocytes to the site of infection. We observed increased
expression of the key chemokines relevant for inflammatory
monocyte recruitment, i.e. CCL2 and CCL7 [46] as well as their
receptor CCR2, in the absence of PPARc in myeloid cells. CCL2
and CCR2 are target genes of PPARc [34], which again supports
Figure 6. Enhanced recruitment of inflammatory monocytes to the site of infection in LysM-PPARc
KO mice. LysM- PPARc
WT and LysM-
PPARc
KO mice were infected i.p. with Listeria (2610
4 CFU). (A) at indicated time points total numbers of CD11b
+ Ly6C
high monocytes in the peritoneal
cavity (PEC), liver and spleen were determined by FACS analysis (B–C) Expression of CCL2, CCL7 and CCR2 in the liver (B) and spleen (C) of infected
mice as determined by qRT-PCR. (D) LSEC isolated from wild type C57BL/6 mice were incubated in vitro with sterile filtered supernatant peritoneal
macrophages from LysM- PPARc
WT and LysM- PPARc
KO mice that were either infected (18 hrs) or left non-infected. The fold increase in expression of
CD54 on the surface of LSEC determined by increase in mean fluorescence intensity by flow cytometry in response to contact with supernatant from
infected vs non-infected peritoneal macrophages was determined after 24 hrs.
doi:10.1371/journal.pone.0037349.g006
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myeloid cells in a cell-intrinsic fashion. As inflammatory mono-
cytes differentiate into dendritic cell subset, so-called tipDCs,
within inflamed tissues [26], it is possible that PPARc also controls
the numbers of tipDCs at the site of infection. This assumption is
supported by a recent publication demonstrating that pharmaco-
logic PPARc activation reduced chemokine-driven recruitment
and local proliferation of tipDCs during viral infection [47]. While
chemokine-expression is sufficient for the recruitment of CCR2
+
monocytes into the spleen [46], expression of CD54 (ICAM-1) was
Figure 7. Transfer of PPARc-deficient macrophages increases the resistance of IFNc
2/2, TNF
2/2 and CCR2
2/2 mice to Listeria
infection. 5610
6 BMDM from LysM- PPARc
WT or LysM- PPARc
KO mice were adoptively transferred into the peritoneal cavity of IFNc
2/2, TNF
2/2 or
CCR2
2/2 mice and two hours later mice (n=10) were infected with 2610
4 CFU of Listeria. (A) Survival of IFNc
2/2 and TNF
2/2 mice after infection
with Listeria. Knockout mice not receiving any cells by adoptive transfer served as controls. Significance for results in IFNc
2/2 and TNF
2/2 mice were
p,0.0001. (B and C) On day 2 after infection, CFU were determined in the homogenates of spleen and liver. One representative out of three
independent experiments is shown.
doi:10.1371/journal.pone.0037349.g007
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[39]. Here, we show that ablation of PPARc in myeloid cells also
led to release of mediators that subsequently increased expression
of CD54 on liver sinusoidal endothelial cells, the cell population
that is responsible for recruitment of immune cells from blood
passing through the liver [39,48]. The recruitment of inflamma-
tory monocytes is of key importance in immune defense against
bacterial, fungal and parasite infections [38,49]. Thus, our results
demonstrate that PPARc in myeloid cells has a central role in
controlling both, the orchestration of bactericidal activity and
immune cell recruitment to the site of infection.
PPARc has been reported to have anti-inflammatory effects in
many immune cell populations. Recently, we have shown that lack
of PPARc in T cells facilitates RORct-mediated development of
pro-inflammatory TH17 cells and thereby promotes central
nervous system autoimmunity [7]. Activation of PPARc in
dendritic cells impairs their ability to elicit T cell mediated
immunity [10]. As augmented expression of PPARc and increased
expression of endogenous ligands generated by the enzyme 12/15-
lipoxygenase are observed under inflammatory conditions [44], it
is possible that PPARc plays a role in the prevention of
overzealous immunity within inflamed tissues, similar to the
expression of co-inhibitory molecules like B7H1 acting on PD1 on
T cells to prevent organ immunopathology [50]. In fact, PPARc in
intestinal epithelial cells is essential to maintain absence of
inflammation from the gut [33]. Our findings raise the question
whether absence of PPARc from myeloid cells, which improves
early anti-bacterial innate immunity, comes at the price of
increased immunopathology to infected organs. However, we
did not observe any increase in liver injury in mice infected with
an LD50 of Listeria monocytogenes lacking PPARc in myeloid cells
(data not shown), indicating that improved anti-bacterial immunity
was not accompanied by increased immunopathology. Even at
higher doses of bacteria (LD80) we did not observe immunopa-
thology to infected organs such as the liver in LysM- PPARc
KO
mice. Only when challenged with very high numbers of bacteria
(1006 LD50) this resistance to infection was broken and mice
lacking PPARc in myeloid cells then died even more rapidly than
their wildtype littermates. The balance between pro- and anti-
inflammatory signals, such as IL-10, TGFb and factors released
from regulatory T cells, decides about the outcome between
immunity and immunopathology to viruses [51], and generation
of regulatory macrophages restricts immunity to bacterial infection
[52]. Whereas all these regulatory mechanisms act during the late
innate or early adaptive phases of the immune response against
infectious pathogens, our results reveal a so far unrecognized early
control of anti-bacterial innate effector mechanisms through
PPARc activation restricting inflammation, which are not coupled
to immunopathology once inactivated. As survival of L. monocyto-
genes in myeloid cells such as dendritic cells is critical for the
successful establishment of infection [53,54], it appears likely that
induction of PPARc by L. monocytogenes is a critical step during
infection and may serve as early escape from innate immunity.
Taken together our results support the notion that PPARc
represents a valuable target for pharmacologic intervention that
when neutralized during bacterial infection would lead to
preferential enhancement of immune-mediated clearance of
intracellular bacteria such as L. monocytogenes without accompany-
ing immunopathology to infected organs like the liver.
Supporting Information
Figure S1 Purity of bone marrow derived macrophages
obtained from LysM- PPARc
WT and LysM- PPARc
KO mice.
Cells were generated as described in Materials and Methods and
on day 7 cells were stained with aCD11b-PerCp-Cy5.5 and F4/
80-FITC.
(TIF)
Figure S2 PPARc ablation in myeloid cells. (A, B) RT-PCR
analysis of mRNA isolated from bone marrow derived macrophag-
es, neutrophil granulocytes, CD11c
+ splenic cells, CD4
+ or CD8
+ T
cells and B cells derived from LysM- PPARc
KO (A) or from bone
marrow derived macrophages from LysMCrexPPARc
flox/flox,
LysMCrexPPARc
WT, PPARc
flox/flox and C57BL/6 mice or
CD8
+ T cells from LysMCrexPPARc
flox/flox mice. Expression of
Cre-recombinase in myeloid cells results in a specific deletion of
exons 1 and 2 of the PPARc gene shown by a truncated 300 bp
fragment of PPARc cDNA, in contrast to the full-length 700 bp
wildtype cDNA. For the remainder of the manuscript LysMCrexP-
PARc
flox/flox are referred to as LysM- PPARc
KO (C) The decrease
of PPARc at the protein level was confirmed by immunoblot in
lysates of peritoneal macrophages from LysMCrexPPARc
flox/flox,
LysMCrexPPARc
WT and PPARc
flox/flox mice. (D) Infecting L.
monocytogenes were detected by DAPI-staining. For better visibility
gray scale conversion of immunofluorescence pictures are shown.
Some infecting Listeria are indicated by arrow heads.
(TIF)
Figure S3 Determination of serum ALT levels. Alanine
aminotransferase levels in serum were determined in mice
LysM-PPARc
WT and LysM-PPARc
KO mice following infection
with different doses of L. monocytogenes.
(TIF)
Figure S4 Enhanced expression of inflammatory cytokies in
PPARc
KO macrophages during Listeria infection in vivo. LysM-
PPARc
WT and LysM-PPARc
KO mice were infected with
2610
4 CFU of L. monocytogenes. At indicated time points peritoneal
macrophages were isolated and the expression of IFNc, TNFa, IL-
6 and IL-12 was assessed by qRT-PCR.
(TIF)
Figure S5 Gating strategy and representative flow cytometric
data for increase of inflammatory monocytes. LysM-PPARc
WT
and LysM-PPARc
KO mice were infected i.p. with Listeria
(2610
4 CFU). (A) Gating strategy for identifying viable inflam-
matory monocytes. (B) At indicated time points the frequency of
CD11b
+ Ly6C
high monocytes within viable cells isolated from the
liver were determined by FACS analysis. Quantification of
inflammatory monocyte cell numbers was done using fluoro-
chrome-labeled microbeads (CountBright absolute counting
beads, life technologies, Invitrogen).
(TIF)
Figure S6 Annexin V staining of inflammatory monocytes from
LysM-PPARc
WT and LysM-PPARc
KO mice. Detection of An-
nexin V levels on the surface of inflammatory monocytes isolated
from the liver of Listeria-infected LysM-PPARc
WT and LysM-
PPARc
KO mice at the indicated time points. 3 mice per group
were analysed, one out of three representative experiments is
shown.
(TIF)
Figure S7 Enhanced expression of CCL2 and CCL7 and their
receptor CCR2 in PPARc
KO macrophages during Listeria
infection in vivo. LysM-PPARc
WT and LysM-PPARc
KO mice
were infected with 2610
4 CFU of Listeria. At indicated time points
peritoneal macrophages were isolated and the expression of
CCL2, CCL7 and CCR2 was assessed by qRT-PCR.
(TIF)
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